The FDA clears the first human age-reversal trial — Sinclair's epigenetic reprogramming study launches next month; a rhetoric professor gives AI slop a formal seven-layer academic definition; a new paper coins UNDCS to name the regulatory gap agentic clinical AI is falling through; ICU AI decision support is outpacing nursing training and liability frameworks; and Auburn engineers watch WarGames to understand AI risk.